The Pritzker Organization
VC Fund
Chicago, United States
The Pritzker Organization is a private investment firm that funds, acquires, and builds companies.TPO is focused on partnering with exceptional leaders to create value across a wide range of industries. TPO looks for opportunities where it can create value for the family's interests and those of its partners and colleagues over a significanttime horizon. For more than 60 years, TPO has overseen and guided the development of dozens of portfolio companies across a wide variety of industries, including manufacturing, logistics, life sciences, hospitality, healthcare, and services.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 56%
Last updated:
For AI agents: llms.txt
Industries The Pritzker Organization invests in
Stages The Pritzker Organization invests in
Countries The Pritzker Organization invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 4 (22%)
- Mobile 2 (11%)
- Payments 2 (11%)
- Software 2 (11%)
- Biotechnology 2 (11%)
Stage
- Series A 3 (17%)
- Private Equity 3 (17%)
- Seed 2 (11%)
- Series B 2 (11%)
- Series C 2 (11%)
Country
- United States 8 (44%)
- Spain 1 (6%)
- Canada 1 (6%)
- United Kingdom 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jason Pritzker
Managing Director
|
Managing Director | Total investments: 5 | Find email | |
|
Joseph Gleberman
Chief Executive Officer
|
Chief Executive Officer | Total investments: 6 | Find email | |
|
Billy Nand
Managing Director
|
Managing Director | Total investments: 2 | Find email | |
|
Thomas Pritzker
Founder , President , EOS Integrator , Fractional Executive , Executive Adviser & Board Member
|
Founder , President , EOS Integrator , Fractional Executive , Executive Adviser & Board Member | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Zephyr is a platform for technology-enabled home services developed with the technician at its core. | $60M / Private Equity / Oct 21, 2024 | ||
| Black Buffalo is a smokeless tobacco alternative that has the same look, feel, smell, and experience as traditional dipping products like Copenhagen or Skoal, without using tobacco leaves or stems. The product comes in both long-cut and pouch varieties and contains pharmaceutical-grade nicotine. | $30M / Series A / May 31, 2022 | ||
| NationsBenefits® is a leading supplemental benefits company that provides managed care organizations customized healthcare management solutions based on clinically focused interventions that maximize quality and deliver value-based outcomes. | Private Equity / Apr 07, 2022 | ||
| NationsBenefits® is a leading supplemental benefits company that provides managed care organizations customized healthcare management solutions based on clinically focused interventions that maximize quality and deliver value-based outcomes. | $170M / Debt Financing / Aug 26, 2021 | ||
| IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs). As an innovative leader in discovery and application of biomarkers and new targets to monitor and cure IMIDs, we create value through the combination of the world's largest IMID biobank, extensive relevant clinical expertise, high-throughput genomic andgenetic analysis, and intellectual property. IMIDomics is located at Vall d'Hebron Hospital in Barcelona, Spain and on the HudsonAlpha Institute campus in Huntsville, Alabama. | $16.5M / Series A / Jul 27, 2021 | ||
| Dataminr is an AI platform that detects the earliest signs of high-impact events and emerging risks from publicly available information. It discovers, distills, and delivers alerts from the increasingly diverse and complex landscape of publicly available information including social media, blogs, information sensors, and the dark web, ensuring thatbusinesses have the knowledge they need to act with confidence. | $475M / Series F / Mar 23, 2021 | ||
| Snoozeal was founded in 2015 in United Kingdom. Co-founder Prof. Dr Anshul Sama, working in a multidisciplinary sleep team, was deeply empathic with many of his patients that were struggling with conventional treatment options that had failed to change in the last two decades. Not dissimilar to practice in many parts of conventional medicine, theemphasis was on treatment of the end result (i.e. splinting the airway open) rather than treating the root cause- collapse of airway due to excessive loss of muscle tone. Over the years Prof Sama came across many devices, all of which had to be worn during sleep, were invariably uncomfortable, only effective when in use and further disrupted the already poor sleep quality. | $10M / Series C / Sep 16, 2020 | ||
| Snoozeal was founded in 2015 in United Kingdom. Co-founder Prof. Dr Anshul Sama, working in a multidisciplinary sleep team, was deeply empathic with many of his patients that were struggling with conventional treatment options that had failed to change in the last two decades. Not dissimilar to practice in many parts of conventional medicine, theemphasis was on treatment of the end result (i.e. splinting the airway open) rather than treating the root cause- collapse of airway due to excessive loss of muscle tone. Over the years Prof Sama came across many devices, all of which had to be worn during sleep, were invariably uncomfortable, only effective when in use and further disrupted the already poor sleep quality. | Series B / Jun 17, 2019 | ||
| Financeit offers a comprehensive suite of tools and technologies designed to simplify complex sales transactions for businesses and their customers. Financeit's point-of-sale financing platform helps businesses of any size close more sales by offering customers affordable monthly payment options for their next big home improvement, vehicle orretail purchase.For larger enterprise businesses, Financeit delivers an integrated suite of home improvement solutions at scale, including leads and workflow management, live contact agents, financing and promotions, performance assurance and category development.Financeit has partnered with over 8,000 merchants to process more than $5 billion in loan applications and was named Canadian Lenders Association's 2019 Company of the Year in Lending. | $17M / Series C / Oct 06, 2016 | ||
| Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating HepatitisC and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California. | $215M / Series E / Sep 15, 2016 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does The Pritzker Organization invest in?
The Pritzker Organization invests primarily in Health Care, Mobile and Payments startups, most often at Series A and Private Equity stage. Most of the 18 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact The Pritzker Organization?
Public channels for The Pritzker Organization include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at The Pritzker Organization?
The team at The Pritzker Organization includes Jason Pritzker (Managing Director), Joseph Gleberman (Chief Executive Officer) and Billy Nand (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!